2016
DOI: 10.2174/1381612822666161006160005
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Signalling Pathways in Hepatocellular carcinoma

Abstract: This review reveals that oncogenes, especially microRNAs that are conserved across species and interfere with signalling pathways might be used as promising strategies for halting or reversing the progression of HCC.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
23
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(23 citation statements)
references
References 0 publications
0
23
0
Order By: Relevance
“…Pathway analysis from KEGG and Panther demonstrated that tight junction and Wnt signaling pathway are among the most relevant pathways for HCC. Tight junction signaling contributes to pathogenesis of GC and CRC, plays functional roles in epithelial-to-mesenchymal transition and viral entry, and could be used as potential targets for gastrointestinal and liver disease; while Wnt signaling pathway is well known to impact on hepatocarcinogenesis and HCC progression [42][43][44][45]. These results suggested that these DECs may participate in HCC progression by regulating their parental genes.…”
Section: Discussionmentioning
confidence: 94%
“…Pathway analysis from KEGG and Panther demonstrated that tight junction and Wnt signaling pathway are among the most relevant pathways for HCC. Tight junction signaling contributes to pathogenesis of GC and CRC, plays functional roles in epithelial-to-mesenchymal transition and viral entry, and could be used as potential targets for gastrointestinal and liver disease; while Wnt signaling pathway is well known to impact on hepatocarcinogenesis and HCC progression [42][43][44][45]. These results suggested that these DECs may participate in HCC progression by regulating their parental genes.…”
Section: Discussionmentioning
confidence: 94%
“…Like all other types of cancers, the onset and progression of HCC is driven by various signaling pathways, including Wnt-βcatenin, Hedgehog, Raf/MEK/ERK, Met-HGF, and so forth. 28,29 Among which, mTOR signaling was selected for further exploration of the mechanism of HEIH, since it has been widely reported as a downstream signaling of F I G U R E 5 Effects of HEIH silence together with miR-199a-3p suppression on Hep3B cells growth and metastasis. A, miR-199a-3p expression was tested by qRT-PCR, after Hep3B cells were transfected with miR-199a-3p inhibitor or NC.…”
Section: Discussionmentioning
confidence: 99%
“…With tumor tissues growing, one of the critical mediators of hypoxic responses is the hypoxia-inducible factor 1a (HIF-1a). Increasing evidence have demonstrated that the activation of PI3K/AKT signaling pathway elevates VEGF expression by up-regulating HIF-1a Blagotinsek and Rozman, 2017;Kim et al, 2017). Thus, identification of drugs that inhibit PI3K/AKT signaling pathway and decrease VEGF and HIF-1a expression is instructive for treating HCC.…”
Section: Introductionmentioning
confidence: 99%